DA32 Life Science Tech Acquisition Corp.

Status: Pre-Deal
U=S
IPO Proceeds, $M $200.00M
IPO Date Jul 28, 2021
CEO Steve Kafka
Left Lead JP Morgan
IPO Cash in Trust 100.0%
SPAC Tenor 24 months
IPO Sector Healthcare

Life sciences

IPO Geography Global
Target Company TBD
Deal Announced TBD
Deal Size, $M TBD
Deal Geography TBD
Deal Sector TBD
SEC Filings www.sec.gov
DALS


Sign up for Free Trial

No credit card required

Sign in for more data on DA32 Life Science Tech Acquisition Corp.:

  • 8 directors & officers
  • 3 filings and events
  • 2 underwriters